Trajectories of childhood immune development and respiratory health relevant to asthma and allergy

  1. Howard HF Tang  Is a corresponding author
  2. Shu Mei Teo
  3. Danielle CM Belgrave
  4. Michael D Evans
  5. Daniel J Jackson
  6. Marta Brozynska
  7. Merci MH Kusel
  8. Sebastian L Johnston
  9. James E Gern
  10. Robert F Lemanske
  11. Angela Simpson
  12. Adnan Custovic
  13. Peter D Sly
  14. Patrick G Holt
  15. Kathryn E Holt
  16. Michael Inouye  Is a corresponding author
  1. Baker Heart and Diabetes Institute, Australia
  2. Imperial College London, United Kingdom
  3. University of Wisconsin School of Medicine and Public Health, United States
  4. University of Western Australia, Australia
  5. University of Manchester, United Kingdom
  6. The University of Melbourne, Australia
  7. University of Cambridge, United Kingdom

Abstract

Events in early life contribute to subsequent risk of asthma; however, the causes and trajectories of childhood wheeze are heterogeneous and do not always result in asthma. Similarly, not all atopic individuals develop wheeze, and vice versa. The reasons for these differences are unclear. Using unsupervised model-based cluster analysis, we identified latent clusters within a prospective birth cohort with deep immunological and respiratory phenotyping. We characterised each cluster in terms of immunological profile and disease risk, and replicated our results in external cohorts from the UK and USA. We discovered three distinct trajectories, one of which is a high-risk 'atopic' cluster with increased propensity for allergic diseases throughout childhood. Atopy contributes varyingly to later wheeze depending on cluster membership. Our findings demonstrate the utility of unsupervised analysis in elucidating heterogeneity in asthma pathogenesis and provide a foundation for improving management and prevention of childhood asthma.

Data availability

This study utilises extensive data from human subjects, specifically paediatric cohorts, for which eLife's policies recognise that there can be strong reasons to restrict access. For each of the cohorts involved in our study (CAS, COAST, MAAS), parents were consented on the use of biomedical data for allergy and asthma research, but not for the open sharing of their or their children's data. Studies were run in the late 1990s and early 2000s and we do not have ethics permission to attempt to recontact families to seek consent. Importantly, we note that key data features could risk re-identification of subjects (e.g. demographic data from small communities).However, we have provided public data at the summary level which can be used for subsequent studies, such as replication and meta-analysis. This is standard practice in sensitive data settings, such as genome-wide association studies. These data have been uploaded as Excel spreadsheets to FigShare for ease of data extraction:Supplementary Table 4 https://figshare.com/articles/Supplementary_File_1_1/6934052Supplementary Table 7 https://figshare.com/articles/Supplementary_File_1_2/6934055

Article and author information

Author details

  1. Howard HF Tang

    Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia
    For correspondence
    Howard.Tang@baker.edu.au
    Competing interests
    The authors declare that no competing interests exist.
  2. Shu Mei Teo

    Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Danielle CM Belgrave

    Department of Paediatrics, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Michael D Evans

    University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7449-3993
  5. Daniel J Jackson

    University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Marta Brozynska

    Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Merci MH Kusel

    Telethon Kids Institute, University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Sebastian L Johnston

    Airway Disease Infection Section, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. James E Gern

    University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Robert F Lemanske

    University of Wisconsin School of Medicine and Public Health, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Angela Simpson

    Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Adnan Custovic

    Department of Paediatrics, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5218-7071
  13. Peter D Sly

    Telethon Kids Institute, University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  14. Patrick G Holt

    Telethon Kids Institute, University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  15. Kathryn E Holt

    Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  16. Michael Inouye

    Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    mi336@medschl.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9413-6520

Funding

National Health and Medical Research Council (1049539)

  • Michael Inouye

National Health and Medical Research Council (PhD Scholarship)

  • Howard HF Tang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Ethics approval and consent requirements for each cohort were met as follows: The CAS study was approved by the ethics committees of the King Edward Memorial and Princess Margaret Hospitals in Western Australia; fully informed parental consent was obtained for all subjects. The COAST study was approved by the Human Subjects Committee of the University of Wisconsin. The MAAS study was approved by a Manchester Local Research Ethics Committee (ERP/94/032; SOU/00/258; 03/SM/400; Study registration ISRCTN72673620); fully informed parental consent was obtained for all subjects across all cohorts.

Copyright

© 2018, Tang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,947
    views
  • 291
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Howard HF Tang
  2. Shu Mei Teo
  3. Danielle CM Belgrave
  4. Michael D Evans
  5. Daniel J Jackson
  6. Marta Brozynska
  7. Merci MH Kusel
  8. Sebastian L Johnston
  9. James E Gern
  10. Robert F Lemanske
  11. Angela Simpson
  12. Adnan Custovic
  13. Peter D Sly
  14. Patrick G Holt
  15. Kathryn E Holt
  16. Michael Inouye
(2018)
Trajectories of childhood immune development and respiratory health relevant to asthma and allergy
eLife 7:e35856.
https://doi.org/10.7554/eLife.35856

Share this article

https://doi.org/10.7554/eLife.35856

Further reading

    1. Computational and Systems Biology
    2. Microbiology and Infectious Disease
    Gaetan De Waele, Gerben Menschaert, Willem Waegeman
    Research Article

    Timely and effective use of antimicrobial drugs can improve patient outcomes, as well as help safeguard against resistance development. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is currently routinely used in clinical diagnostics for rapid species identification. Mining additional data from said spectra in the form of antimicrobial resistance (AMR) profiles is, therefore, highly promising. Such AMR profiles could serve as a drop-in solution for drastically improving treatment efficiency, effectiveness, and costs. This study endeavors to develop the first machine learning models capable of predicting AMR profiles for the whole repertoire of species and drugs encountered in clinical microbiology. The resulting models can be interpreted as drug recommender systems for infectious diseases. We find that our dual-branch method delivers considerably higher performance compared to previous approaches. In addition, experiments show that the models can be efficiently fine-tuned to data from other clinical laboratories. MALDI-TOF-based AMR recommender systems can, hence, greatly extend the value of MALDI-TOF MS for clinical diagnostics. All code supporting this study is distributed on PyPI and is packaged at https://github.com/gdewael/maldi-nn.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Sanjarbek Hudaiberdiev, Ivan Ovcharenko
    Research Article

    Enhancers and promoters are classically considered to be bound by a small set of transcription factors (TFs) in a sequence-specific manner. This assumption has come under increasing skepticism as the datasets of ChIP-seq assays of TFs have expanded. In particular, high-occupancy target (HOT) loci attract hundreds of TFs with often no detectable correlation between ChIP-seq peaks and DNA-binding motif presence. Here, we used a set of 1003 TF ChIP-seq datasets (HepG2, K562, H1) to analyze the patterns of ChIP-seq peak co-occurrence in combination with functional genomics datasets. We identified 43,891 HOT loci forming at the promoter (53%) and enhancer (47%) regions. HOT promoters regulate housekeeping genes, whereas HOT enhancers are involved in tissue-specific process regulation. HOT loci form the foundation of human super-enhancers and evolve under strong negative selection, with some of these loci being located in ultraconserved regions. Sequence-based classification analysis of HOT loci suggested that their formation is driven by the sequence features, and the density of mapped ChIP-seq peaks across TF-bound loci correlates with sequence features and the expression level of flanking genes. Based on the affinities to bind to promoters and enhancers we detected five distinct clusters of TFs that form the core of the HOT loci. We report an abundance of HOT loci in the human genome and a commitment of 51% of all TF ChIP-seq binding events to HOT locus formation thus challenging the classical model of enhancer activity and propose a model of HOT locus formation based on the existence of large transcriptional condensates.